Omega Healthcare Investors Inc. reported net income of $185 million, or $0.59 per diluted share, for the third quarter of 2025, up from $115 million, or $0.42 per diluted share, in the third quarter of 2024. Adjusted Funds From Operations (AFFO) for the quarter were $243 million, or $0.79 per diluted share, compared to $203 million, or $0.74 per diluted share, in the prior-year period. The company completed $978 million in new investments year-to-date and closed a new $2.3 billion unsecured credit facility. Omega also repaid $600 million of senior unsecured notes in the fourth quarter. Additionally, the company increased its full-year adjusted FFO guidance to a range of $2.90 to $2.98 per share. In the third quarter, Genesis Healthcare, an operator in Omega's portfolio, filed for Chapter 11 bankruptcy protection, and Omega provided $8.0 million in debtor-in-possession financing. Genesis made all required contractual rent and interest payments during the quarter, and Omega recorded $12.9 million in rental income from Genesis.